pseudomyxoma peritonei

Summary

Summary: A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Segen, Dictionary of Modern Medicine, 1992)

Top Publications

  1. ncbi New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
    Paul H Sugarbaker
    Washington Cancer Institute, 106 Irving Street, NW Suite 3900 Washington, DC 20020, USA
    Lancet Oncol 7:69-76. 2006
  2. ncbi Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour
    Colin J R Stewart
    Departments of Histopathology and Gynaecological Oncology, King Edward Memorial Hospital, Perth, Western Australia
    Pathology 38:534-8. 2006
  3. ncbi Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Terence C Chua
    University of New South Wales, St George Hospital, Sydney, Australia
    J Clin Oncol 30:2449-56. 2012
  4. ncbi CT in pseudomyxoma peritonei: a review of 17 cases
    T V C Sulkin
    Departments of Clinical Radiology, North Hampshire Hospital NHS Trust, Basingstoke, UK
    Clin Radiol 57:608-13. 2002
  5. ncbi Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution
    Terence C Chua
    Department of Surgery, St George Hospital, University of New South Wales, Sydney, NSW, Australia
    Ann Surg Oncol 16:1903-11. 2009
  6. pmc Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy
    Thomas J Miner
    Memorial Sloan Kettering Cancer Center, New York, New York 10021 USA
    Ann Surg 241:300-8. 2005
  7. ncbi Mucinous neoplasms of the appendix and peritoneum
    Nicole C Panarelli
    Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York 10065, USA
    Arch Pathol Lab Med 135:1261-8. 2011
  8. ncbi Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification
    Reetesh K Pai
    Department of Pathology, Stanford University School of Medicine, CA 94305, USA
    Adv Anat Pathol 12:291-311. 2005
  9. ncbi Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis
    B M Ronnett
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland 21231, USA
    Cancer 92:85-91. 2001
  10. ncbi Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin
    Haney Youssef
    Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, UK
    Dis Colon Rectum 54:293-9. 2011

Research Grants

  1. TK-based methods to improve radioimmunotherapy
    Janina Baranowska Kortylewicz; Fiscal Year: 2006

Detail Information

Publications230 found, 100 shown here

  1. ncbi New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
    Paul H Sugarbaker
    Washington Cancer Institute, 106 Irving Street, NW Suite 3900 Washington, DC 20020, USA
    Lancet Oncol 7:69-76. 2006
    ..In the absence of a phase III study, this new combined treatment should be regarded as the standard of care for epithelial appendiceal neoplasms and pseudomyxoma peritonei syndrome.
  2. ncbi Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour
    Colin J R Stewart
    Departments of Histopathology and Gynaecological Oncology, King Edward Memorial Hospital, Perth, Western Australia
    Pathology 38:534-8. 2006
    It is currently accepted that primary ovarian tumours rarely, if ever, give rise to mucinous ascites/pseudomyxoma peritonei (PMP) which most commonly results from the intra-abdominal spread of an appendiceal mucinous neoplasm...
  3. ncbi Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Terence C Chua
    University of New South Wales, St George Hospital, Sydney, Australia
    J Clin Oncol 30:2449-56. 2012
    b>Pseudomyxoma peritonei (PMP) originating from an appendiceal mucinous neoplasm remains a biologically heterogeneous disease...
  4. ncbi CT in pseudomyxoma peritonei: a review of 17 cases
    T V C Sulkin
    Departments of Clinical Radiology, North Hampshire Hospital NHS Trust, Basingstoke, UK
    Clin Radiol 57:608-13. 2002
    To describe the computed tomography (CT) findings in pseudomyxoma peritonei.
  5. ncbi Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution
    Terence C Chua
    Department of Surgery, St George Hospital, University of New South Wales, Sydney, NSW, Australia
    Ann Surg Oncol 16:1903-11. 2009
    ..CRS) and perioperative intraperitoneal chemotherapy (PIC) has been recognized as a treatment option for pseudomyxoma peritonei. This study reports the survival outcomes, clinicopathological prognostic factors, and a learning curve ..
  6. pmc Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy
    Thomas J Miner
    Memorial Sloan Kettering Cancer Center, New York, New York 10021 USA
    Ann Surg 241:300-8. 2005
    b>Pseudomyxoma peritonei (PMP) is a clinical syndrome with a poorly defined natural history. Relative contributions of tumor biology, patient selection, and the extent of treatment on ultimate outcome are not well characterized.
  7. ncbi Mucinous neoplasms of the appendix and peritoneum
    Nicole C Panarelli
    Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York 10065, USA
    Arch Pathol Lab Med 135:1261-8. 2011
    ..Extra-appendiceal spread of these tumors is the most common etiology of pseudomyxoma peritonei , which is a descriptive term encompassing a number of neoplastic and nonneoplastic peritoneal disorders...
  8. ncbi Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification
    Reetesh K Pai
    Department of Pathology, Stanford University School of Medicine, CA 94305, USA
    Adv Anat Pathol 12:291-311. 2005
    b>Pseudomyxoma peritonei is an overused and underspecified condition that has garnered much attention in the historic literature...
  9. ncbi Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis
    B M Ronnett
    Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland 21231, USA
    Cancer 92:85-91. 2001
    b>Pseudomyxoma peritonei (PMP) is a poorly understood condition characterized by disseminated intraperitoneal mucinous tumors, often with mucinous ascites...
  10. ncbi Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin
    Haney Youssef
    Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, UK
    Dis Colon Rectum 54:293-9. 2011
    b>Pseudomyxoma peritonei syndrome is a clinical entity characterized by mucinous ascites usually originating from a perforated mucinous appendiceal tumor...
  11. ncbi Mucin as a therapeutic target in pseudomyxoma peritonei
    Haroon A Choudry
    Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15261, USA
    J Surg Oncol 106:911-7. 2012
    b>Pseudomyxoma peritonei (PMP) is characterized by intraperitoneal dissemination of mucinous ascites. This malignancy frequently recurs despite aggressive locoregional therapies, demonstrates chemo-insensitivity and lacks targeted therapies...
  12. doi Pseudomyxoma peritonei
    Robert M Smeenk
    Curr Probl Surg 45:527-75. 2008
  13. ncbi A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei
    Krishna Pillai
    UNSW Department of Surgery, St George Clinical School, Kogarah, NSW, Australia
    Int J Cancer 134:478-86. 2014
    Although numerous clinical attempts have been made to disintegrate mucin secreted by pseudomyxoma peritonei (PMP), none are clinically recommended...
  14. ncbi Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei
    Z Güner
    Department for Visceral and Transplant Surgery, Medical School of Hannover, 30623 Hannover, Germany
    Int J Colorectal Dis 20:155-60. 2005
    Surgical improvement can be achieved in selected patients with pseudomyxoma peritonei (PMP) by major cytoreductive surgery and intraperitoneal chemotherapy (IPEC)...
  15. ncbi Appendiceal mucinous neoplasms: controversial issues
    Joseph Misdraji
    Department of Pathology, Massachusetts General Hospital, Boston 02114, USA
    Arch Pathol Lab Med 134:864-70. 2010
    Low grade appendiceal mucinous neoplasms can spread to the peritoneum as pseudomyxoma peritonei even though they are not obviously invasive in the appendix...
  16. ncbi Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix
    C Pablo Carmignani
    Washington Cancer Institute, Washington, DC 20010, USA
    J Surg Oncol 87:162-6. 2004
    ..The use of these tumor markers in mucinous epithelial tumors of the appendix has not been previously determined...
  17. ncbi Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy
    D Elias
    Department of Oncologic Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Eur J Surg Oncol 36:456-62. 2010
    To analyze a large series of patients with pseudomyxoma peritonei (PMP) treated with cytoreductive surgery associated with perioperative intraperitoneal chemotherapy (PIC) in 18 French-speaking centers.
  18. ncbi Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei
    Akshat Saxena
    Department of Surgery, St George Hospital, University of New South Wales, Sydney, Australia
    Ann Surg Oncol 17:1291-301. 2010
    ..intraperitoneal chemotherapy (PIC) has demonstrated improved survival in selected patients with pseudomyxoma peritonei (PMP)...
  19. ncbi Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome
    P H Sugarbaker
    Washington Cancer Institute, Washington, DC, USA
    Eur J Surg Oncol 27:239-43. 2001
    ..b>Pseudomyxoma peritonei may be especially appropriate for these aggressive local regional treatments...
  20. pmc Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis
    Cristina Semino-Mora
    Laboratory of Gastrointestinal and Liver Studies, Department of Medicine, Uniformed Services University and United States Military Cancer Institute, Bethesda, MD 20814, USA
    Ann Surg Oncol 15:1414-23. 2008
    b>Pseudomyxoma peritonei (PMP) is characterized by peritoneal tumors arising from a perforated appendiceal adenoma or adenocarcinoma, but associated entry of enteric bacteria in the peritoneum has not been considered as a cofactor...
  21. ncbi Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)
    Brendan Moran
    Colorectal Research Unit, North Hampshire Hospital, Basingstoke, Hampshire, UK
    J Surg Oncol 98:277-82. 2008
    b>Pseudomyxoma peritonei (PMP) is a rare condition mostly originating from low malignant potential mucinous tumours of the appendix...
  22. ncbi High expression of RELP (Reg IV) in neoplastic goblet cells of appendiceal mucinous cystadenoma and pseudomyxoma peritonei
    Kukka Heiskala
    Department of Pathology, Haartman Institute University of Helsinki, PO Box 21 Haartmaninkatu 3, FIN 00014, Helsinki, Finland
    Virchows Arch 448:295-300. 2006
    ..RELP in the neoplastic goblet cells of appendiceal mucinous cystadenomas and in the epithelial implants of pseudomyxoma peritonei (PMP)...
  23. pmc Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Robert M Smeenk
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Ann Surg 245:104-9. 2007
    To evaluate the survival of patients with pseudomyxoma peritonei (PMP) treated by cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC), and to identify factors with prognostic value.
  24. ncbi Learning curve of combined modality treatment in peritoneal surface disease
    R M Smeenk
    Department of Surgery, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Br J Surg 94:1408-14. 2007
    ..Cytoreductive surgery with intraperitoneal chemotherapy has emerged as a new standard approach for peritoneal surface disease. This study investigated the learning curve of this combined modality treatment at a single institute...
  25. ncbi Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei
    Marcello Deraco
    Department of Surgery, Melanoma and Sarcoma Unit, National Cancer Institute of Milan, Italy
    Ann Surg Oncol 11:393-8. 2004
    b>Pseudomyxoma peritonei (PMP) is a rare disease with a poor prognosis characterized by a complete redistribution of mucin within the peritoneal cavity...
  26. ncbi MUC2, MUC5AC and MUC5B in the mucus of a patient with pseudomyxoma peritonei: biochemical and immunohistochemical study
    Anwar S Mall
    Department of Surgery, University of Cape Town, South Africa
    Pathol Int 57:537-47. 2007
    A 58-year-old man with a 1 year history of progressive abdominal distension underwent a laparotomy for pseudomyxoma peritonei. The mucin was identified and characterized in the present study...
  27. ncbi Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process
    Faheez Mohamed
    The Washington Cancer Institute, Washington Hospital Center, Washington, District of Columbia 20010, USA
    J Surg Oncol 86:10-5. 2004
    Three distinct morphologic types of pseudomyxoma peritonei syndrome have been defined: disseminated peritoneal adenomucinosis (DPAM), peritoneal mucinous carcinoma (PMCA), and a hybrid morphologic type...
  28. ncbi Pseudomyxoma peritonei: some different sonographic findings
    Yanhong Que
    Department of Ultrasound, First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China
    Abdom Imaging 37:843-8. 2012
    The purpose of our study was to assess the sonographic features of pseudomyxoma peritonei (PMP).
  29. ncbi Survival of patients with pseudomyxoma peritonei treated by serial debulking
    P Jarvinen
    Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland
    Colorectal Dis 12:868-72. 2010
    We evaluated the outcome of patients with pseudomyxoma peritonei (PMP) after traditional debulking...
  30. ncbi Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin secreted in pseudomyxoma peritonei
    Krishna Pillai
    Department of Surgery, Hepatobiliary and Surgical Oncology Unit, University of New South Wales, St George Hospital, Kogarah, NSW, Australia
    J Surg Res 174:e69-73. 2012
    This study examines the potential efficacy of hydrogen peroxide and ascorbic acid in the dissolution of mucinous ascites from pseudomyxoma peritonei.
  31. pmc Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4)
    Chin Fan Chen
    Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    World J Surg Oncol 6:118. 2008
    b>Pseudomyxoma peritonei (PMP) is a rare condition characterized by mucinous tumors, disseminated intra-peritoneal implants, and mucinous ascites. So far its diagnosis remains challenging to most clinicians.
  32. ncbi [Syndrome of pseudomyxoma peritonei--description of three cases and survey of the problem]
    Z Kinkor
    Bioptická laborator, s r o, a Siklův ústav patologie, LF UK, Plzen
    Ceska Gynekol 70:67-72. 2005
    To describe personal experience with three heterogeneous cases of pseudomyxoma peritonei. Review of the literature concentrates on the pathogenesis and biologic spectrum of the rare syndrome.
  33. pmc Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei
    Tommaso Cioppa
    Department of General and Oncological Surgery, San Giuseppe Hospital, Viale Boccaccio, 50053 Empoli, Florence, Italy
    World J Gastroenterol 14:6817-23. 2008
    ..of hyperthermic intraperitoneal chemotherapy (HIPEC) that has been accepted as the standard treatment for pseudomyxoma peritonei (PMP), with special regard to morbidity, overall survival (OS) and disease free survival (DFS) over 10 ..
  34. ncbi [Appendiceal mucocele causing pseudomyxoma peritonei]
    J Vana
    Chirurgische Abteilung des Krankenhauses mit Poliklinik, Zilina, Slowakische Republik
    Zentralbl Chir 130:177-80. 2005
    The authors present the case of a very rare pseudomyxoma peritonei as a late complication of appendectomy. The definite diagnosis was established 11 years after appendectomy for appendiceal mucocele...
  35. ncbi Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate
    Terence C Chua
    UNSW Department of Surgery, Cancer Care Centre, St George Hospital, Kogarah, Sydney, Australia
    Ann Surg 253:769-73. 2011
    ..combined with perioperative intraperitoneal chemotherapy (PIC) is a recognized management strategy for pseudomyxoma peritonei. We seek to evaluate the outcomes of patients treated upfront with CRS PIC compared to patients undergoing ..
  36. ncbi Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei
    Terence C Chua
    UNSW Department of Surgery, St George Hospital, Kogarah, Sydney, NSW, Australia
    Ann Surg Oncol 18:1582-9. 2011
    This study evaluates the accuracy of computed tomography (CT) scoring of the peritoneal cancer index (PCI) and examines its association with surgical morbidity and outcomes in pseudomyxoma peritonei.
  37. ncbi Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved
    Sanjeev Dayal
    Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, United Kingdom
    Dis Colon Rectum 56:1366-72. 2013
    b>Pseudomyxoma peritonei is a diffuse peritoneal malignancy that generally originates form a perforated appendiceal tumor...
  38. ncbi Incidental finding of pseudomyxoma peritonei at primary cesarean section
    Ben Abdu
    Obstetrics and Gynecology, University of Tennessee Health Science Center, Chattanooga, Tennessee, USA
    Am J Perinatol 26:633-5. 2009
    ..may rupture, leading to intraperitoneal seeding of the peritoneum and producing the clinical picture of pseudomyxoma peritonei (PMP)...
  39. ncbi Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
    Kjersti Flatmark
    Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, N 0310 Oslo, Norway
    Hum Pathol 41:1109-19. 2010
    ..Five human tumors and corresponding orthotopic animal models of human pseudomyxoma peritonei and peritoneal mucinous carcinomatosis from colorectal carcinoma were extensively characterized by ..
  40. ncbi Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence
    F Alexander-Sefre
    The North Hampshire Hospital, Basingstoke, UK
    Colorectal Dis 7:382-6. 2005
    To assess the potential value of pre-operative CEA, CA 125 and CA 19-9 in identifying Pseudomyxoma peritonei (PMP) patients at risk of recurrence following complete cytoreductive surgery and intraperitoneal chemotherapy.
  41. pmc Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei
    Haroon Asif Choudry
    Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Ann Surg Oncol 19:1402-9. 2012
    Intraperitoneal accumulation of mucinous ascites in pseudomyxoma peritonei (PMP) promotes an inflammatory/fibrotic reaction that progresses to bowel obstruction and eventual patient demise...
  42. ncbi [Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy]
    Dominique Elias
    Département de Chirurgie Générale Carcinologique, Institut Gustave Roussy, rue Camille Desmoulins, 94805, Villejuif Cedex
    Gastroenterol Clin Biol 27:407-12. 2003
    b>Pseudomyxoma peritonei remains a fatal disease. This clinical pathological entity based on the presence of mucin includes different prognostic groups...
  43. ncbi Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis
    Katherine McBride
    University of Vermont College of Medicine, Burlington, Vermont 31410, USA
    J Surg Res 183:246-52. 2013
    b>Pseudomyxoma peritonei (PMP) is an uncommon but lethal variant of adenocarcinoma...
  44. ncbi Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei
    Shigeki Kusamura
    Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumouri Milano, Milan, Italy
    J Surg Oncol 108:1-8. 2013
    Incomplete cytoreduction (IC) is one of the main prognostic factor in pseudomyxoma peritonei (PMP). We evaluated the ability of preoperative Ca125, CEA, and Ca19-9 to predict IC and prognosis in PMP.
  45. ncbi Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival
    Shreya Shetty
    Department of Surgery, Creighton University Medical Center, Omaha, Nebraska, USA
    Am Surg 79:1171-6. 2013
    The nomenclature and classification of pseudomyxoma peritonei (PMP) is confusing and controversial. Numerous classification systems have been proposed, none of which are easily reproducible or a useful guide for treatment...
  46. pmc A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei
    Jeremy J Gilbreath
    Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA
    Orphanet J Rare Dis 8:105. 2013
    b>Pseudomyxoma peritonei (PMP) is a malignancy characterized by dissemination of mucus-secreting cells throughout the peritoneum...
  47. ncbi Pseudomyxoma peritonei occurring after an uneventful 23 years interval from appendectomy
    Atsuko Taii
    Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science
    Intern Med 46:1109-12. 2007
    ..He then received 3 courses of chemotherapy, but failed to reach a remission. The final diagnosis of pseudomyxoma peritonei was made by means of abdominocentesis, and he underwent debulking surgery...
  48. ncbi Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution
    Cristina Semino-Mora
    Uniformed Services University and United States Military Cancer Institute, Bethesda, Maryland 20814, USA
    Clin Cancer Res 19:3966-76. 2013
    b>Pseudomyxoma peritonei is an understudied cancer in which an appendiceal neoplasm invades the peritoneum and forms tumor foci on abdominal organs...
  49. ncbi Melioidosis presenting as pseudomyxoma peritonei: yet another pretense of the great mimicker: an unreported entity
    Raghavan Velayutham Sugi Subramaniam
    Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
    Surg Infect (Larchmt) 14:415-7. 2013
    ..Melioidosis, a lethal infectious disease caused by Burkholderia pseudomallei, an important human pathogen in tropical regions, is notorious for its diverse clinical presentations...
  50. ncbi Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors
    C R Ferreira
    Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil
    Int J Gynecol Cancer 18:59-65. 2008
    b>Pseudomyxoma peritonei (PMP) is a clinical condition initially thought to be related to ovarian mucinous tumors; however, immunohistochemistry and molecular biology techniques have convincingly made the link to appendiceal mucinous ..
  51. pmc Appendiceal mucocoeles and pseudomyxoma peritonei
    Anupam Dixit
    Colorectal Department, The London Clinic, 20 Devonshire Place, London W1G 6BW, United Kingdom
    World J Gastroenterol 13:2381-4. 2007
    ..or iatrogenic rupture of the mucocoele can lead to mucinous intraperitoneal ascites, a syndrome known as pseudomyxoma peritonei. Optimal management of mucoceles is achieved through accurate preoperative identification and subsequent ..
  52. ncbi Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis
    Shreya Shetty
    Department of Surgery, Creighton University Medical Center, Omaha, NE, USA
    J Surg Res 180:97-103. 2013
    Little information exists on Kras mutations and p53 overexpression in pseudomyxoma peritonei (PMP). These genetic alterations are associated with poorer prognoses in colorectal cancer...
  53. ncbi Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei
    Anh Dang
    Department of Anesthesiology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Cardiothorac Vasc Anesth 21:265-8. 2007
  54. ncbi Pseudomyxoma peritonei (mucinous carcinoma peritonei) preceded by intraductal papillary neoplasm of the bile duct
    Jie Yang Jhuang
    Department of Pathology, National Taiwan University Hospital, 10002 Taipei, Taiwan
    Hum Pathol 43:1148-52. 2012
    b>Pseudomyxoma peritonei (mucinous carcinoma peritonei) is a rare clinical disease. Although most cases derive from appendiceal mucinous tumors, a few are associated with pancreatic intraductal papillary mucinous neoplasms...
  55. ncbi The influence of tumor cell entrapment phenomenon on the natural history of Pseudomyxoma peritonei syndrome
    John Spiliotis
    Department of Surgery, Metaxa Cancer Hospital, Piraeus, Greece
    Hepatogastroenterology 59:705-8. 2012
    b>Pseudomyxoma peritonei syndrome (PMP) may be associated with slow "benign" or malignant process. However, the natural history of this disease is slow progression to death. Its treatment is variable and controversial...
  56. ncbi Potential mucolytic agents for mucinous ascites from pseudomyxoma peritonei
    Krishna Pillai
    Department of Surgery Cancer Research Laboratories, University of New South Wales, Sydney, Australia
    Invest New Drugs 30:2080-6. 2012
    b>Pseudomyxoma peritonei is a disease characterised by the accumulation of mucinous ascites...
  57. pmc Quality of life study following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei including redo procedures
    Rachel Kirby
    Hepatobiliary and Surgical Oncology Unit, UNSW Department of Surgery, St George Hospital, Sydney, NSW 2217, Australia
    Int J Surg Oncol 2013:461041. 2013
    ..was to evaluate the quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. We also conducted an analysis of all patients who underwent CRS and HIPEC for pseudomyxoma peritonei from ..
  58. ncbi Incidental ultrasound diagnosis of pseudomyxoma peritonei in an asymptomatic woman
    S Khan
    Early Pregnancy and Gynaecology Assessment Unit and Department of Surgery, King s College Hospital, London, UK
    Ultrasound Obstet Gynecol 19:410-2. 2002
    An incidental finding of pseudomyxoma peritonei is reported in a woman with a 6-month history of postmenopausal bleeding...
  59. ncbi Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei
    H Andreasson
    Department of Surgical Sciences, Section of Surgery, Uppsala University, S 751 85 Uppsala, Sweden
    Eur J Surg Oncol 38:962-8. 2012
    The aim of this study was to compare debulking surgery and cytoreductive surgery (CRS) in patients with Pseudomyxoma peritonei (PMP) regarding efficacy and safety.
  60. ncbi Pseudomyxoma peritonei
    R M Smeenk
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Cancer Treat Rev 33:138-45. 2007
    b>Pseudomyxoma peritonei (PMP) is a rare condition, which is known for its high mortality when not treated properly. The first step to improve prognosis of these patients is to recognize this clinical syndrome preferably in an early stage...
  61. pmc Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy
    Erika Haase
    Program in Peritoneal Surface Malignancy, Washington Cancer Institute, Washington Hospital Center, Washington, District of Columbia, USA
    World J Surg Oncol 7:48. 2009
    ..Epithelial tumors of the appendix on the other hand are rare and account for only approximately 1% of all colorectal neoplasms; the occurrence of this neoplasm during pregnancy is extremely rare...
  62. ncbi A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei
    Tristan D Yan
    Peritoneal Surface Malignancy Program, Washington Cancer Institute, Washington Hospital Center, 106 Irving Street, NW, Suite 3900N, Washington, DC 20010, USA
    Ann Surg Oncol 14:484-92. 2007
    The efficacy of cytoreductive surgery (CRS) combined with perioperative intraperitoneal chemotherapy (PIC) for patients with pseudomyxoma peritonei (PMP) remains to be established.
  63. pmc Laparoscopic mucin removal in patients with pseudomyxoma peritonei
    Yasushi Kotani
    Department of Obstetrics and Gynecology, Kinki University School of Medicine, Osaka Sayama, Osaka, Japan
    JSLS 13:203-6. 2009
    b>Pseudomyxoma peritonei results from ovarian and appendiceal mucinous tumors. Cyst rupture results in intraabdominal mucin accumulation, leading to abdominal distension. No effective treatment has yet been established...
  64. ncbi The coexistence of low-grade mucinous neoplasms of the appendix and appendiceal diverticula: a possible role in the pathogenesis of pseudomyxoma peritonei
    L W Lamps
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Mod Pathol 13:495-501. 2000
    ..low-grade mucinous neoplasms and to examine the possible role of diverticula in the pathogenesis of pseudomyxoma peritonei. Invasive adenocarcinomas and retention cysts were excluded (six cases)...
  65. ncbi Chemo-hyperthermic peritoneal perfusion (CHPP) for appendiceal pseudomyxoma peritonei
    Kanji Katayama
    First Department of Surgery, University of Fukui, School of Medicine, 23 Shimoaizuki, Matsuoka, Eiheiji cho, Fukui, 910 1193, Japan
    Int J Clin Oncol 14:120-4. 2009
    b>Pseudomyxoma peritonei is derived mostly from the rupture of an appendiceal cystic tumor and produces a large quantity of mucinous substance. Though its malignancy level is low, radical resection is difficult and its prognosis is poor...
  66. ncbi Sciatica caused by pseudomyxoma peritonei
    Hung Lin Lin
    Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan, R O C
    J Chin Med Assoc 72:39-41. 2009
    ..Bilateral ovarian borderline mucinous cystic tumor with pseudomyxoma peritonei (PMP) was diagnosed, and the sciatica was improved dramatically after subsequent abdominal debulking ..
  67. ncbi Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei
    Terence C Chua
    Department of Surgery, University of New South Wales, St George Hospital, Kogarah, Sydney, NSW, Australia
    J Surg Oncol 99:292-5. 2009
    Pleural dissemination of pseudomyxoma peritonei (PMP) is considered an advanced/terminal disease...
  68. ncbi Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei
    S Alves
    Pseudomyxoma Peritonei Centre, Basingstoke and North Hampshire Hospital Foundation Trust, Aldermaston Road, Basingstoke, Hampshire RG24 9NA, UK
    Eur J Surg Oncol 36:1156-61. 2010
    b>Pseudomyxoma peritonei (PMP) is characterized by mucinous ascites, predominantly arising form a perforated tumour of the appendix...
  69. ncbi Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study
    Per Jess
    Department of Surgery, Nordsjaellands Hospital Hillerod, Hillerod, DK 3400, Denmark
    Dis Colon Rectum 51:868-74. 2008
    The modern treatment of pseudomyxoma peritonei is cytoreductive surgery plus intraperitoneal chemotherapy resulting in a survival of up to 70 percent after 20 years...
  70. ncbi Pseudomyxoma peritonei due to mucinous cystadenocarcinoma in situ of the urachus presenting as an inguinal hernia
    Toshiki Shinohara
    Department of Surgery, Sapporo City General Hospital, Sapporo, Japan
    Int J Clin Oncol 11:416-9. 2006
    b>Pseudomyxoma peritonei is generally caused by appendiceal and ovarian tumors. Other primary sites have been rarely reported...
  71. ncbi Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience
    Marco Vaira
    Department of General and Oncological Surgery, San Giuseppe Hospital, Viale Boccaccio, 12, 50053 Empoli, Florence, Italy
    In Vivo 23:639-44. 2009
    b>Pseudomyxoma peritonei (PMP) is a rare peritoneal carcinomatosis, characterized by a slowly progressive disease process with a large amount of mucus containing occasional epithelial cells...
  72. ncbi [Endometrial and endocervical lesions associated with pseudomyxoma peritonei: a case report]
    Ines Samet
    Service d Anatomie et de Cytologie Pathologiques, Hopital Bretonneau, Faculte de Medecine, 37044 Tours cedex 9, France
    Ann Pathol 29:233-7. 2009
    The association of a pseudomyxoma peritonei with a mucinous tumor of the appendix and/or the ovary is regularly reported in the literature. However, in this context, endometrial or endocervical lesions remain exceptional...
  73. ncbi [Pseudomyxoma peritonei: new concept and new therapeutic approach]
    R Loungnarath
    Département de chirurgie colorectale, Centre Hospitalier de l Universite de Montreal, Hopital Saint Luc, Montreal, Quebec, Canada
    Ann Chir 130:63-9. 2005
    b>Pseudomyxoma peritonei is a rare disease, usually diagnosed after the discover of "jelly belly" by laparotomy...
  74. ncbi Pseudomyxoma peritonei: extraperitoneal spread to the pleural cavity and lung
    Bae Young Lee
    Department of Radiology, St Paul s Hospital, Medical College, The Catholic University of Korea, Seoul, Korea
    J Thorac Imaging 19:123-6. 2004
    Abdominal and pelvic recurrence of pseudomyxoma peritonei after the surgery is occasionally seen but extraperitoneal spread and hematogeneous metastases are rare...
  75. pmc Management of pseudomyxoma peritonei
    Zhi Bo Qu
    Department of General Surgery, First Clinical College of Harbin Medical University, Harbin 150001, Heilongjiang Province, China
    World J Gastroenterol 12:6124-7. 2006
    b>Pseudomyxoma peritonei (PMP) is a rare disease...
  76. ncbi Appendiceal pseudomyxoma peritonei in a pregnant woman
    Abu Z Manan
    Department of Surgery, Armed Forces Hospital, King Abdul Aziz Naval Base, PO Box 413, Al Jubail 31951, Kingdom of Saudi Arabia
    Saudi Med J 31:572-4. 2010
    ..We report an unusual case of pseudomyxoma peritonei (PMP) in a 41-year-old full-term pregnant woman...
  77. ncbi Pseudomyxoma peritonei originating from colorectal cancer during pregnancy
    Shinsuke Koyama
    Division of Obstetrics and Gynecology, Department of Specific Organ Regulation, Osaka University Graduate School of Medicine, Osaka, Japan
    J Obstet Gynaecol Res 37:254-8. 2011
    b>Pseudomyxoma peritonei is an extremely rare condition characterized by the presence of gelatinous ascites and disseminated intra-peritoneal mucinous tumors...
  78. ncbi Pseudomyxoma peritonei presenting with femoral hernias and peritonitis
    Akihiro Hosaka
    Department of Surgery, Ome Municipal General Hospital, 16 5, Higashi Ome 4 chome, Ome shi, Tokyo, 198 0042, Japan
    J Gastrointest Surg 11:1576-8. 2007
    b>Pseudomyxoma peritonei is a rare disease characterized by intraperitoneal accumulation of mucinous ascites produced by neoplastic cells, which mostly originate from an appendiceal adenoma...
  79. pmc Soft-tissue images. Pseudomyxoma peritonei and villous adenoma of the appendix
    Shiva Jayaraman
    University of Western Ontorio, Department of Pathology, Faculty of Medicine and Dentistry, London
    Can J Surg 45:90-1. 2002
  80. pmc Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells
    Jerome T O'Connell
    Department of Pathology, University of California at Los Angeles School of Medicine, Los Angeles, California 90024, USA
    Am J Pathol 161:551-64. 2002
    b>Pseudomyxoma peritonei, a syndrome first described by Karl F...
  81. ncbi Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications
    R M Smeenk
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    J Surg Oncol 93:20-3. 2006
    b>Pseudomyxoma peritonei (PMP) is a rare clinical syndrome characterized by intraperitoneal accumulation of mucus produced by neoplastic cells of mostly appendiceal origin...
  82. ncbi MUC2 is a molecular marker for pseudomyxoma peritonei
    Jerome T O'Connell
    Department of Pathology, UCLA School of Medicine, Los Angeles, California 90024, USA
    Mod Pathol 15:958-72. 2002
    b>Pseudomyxoma peritonei, a syndrome first described by Rokitansky in 1842, is an enigmatic, often fatal intra-abdominal disease characterized by dissecting gelatinous ascites and multifocal peritoneal epithelial implants secreting copious ..
  83. ncbi Mucinous adenocarcinoma of the renal pelvis with pseudomyxoma peritonei
    Vinaya B Shah
    Department of Pathology, T N Medical College and B Y L Nair Hospital, Dr A L Nair Road, Bombay Central, Mumbai 400 008, India
    Indian J Pathol Microbiol 51:536-7. 2008
    ..b>Pseudomyxoma peritonei is an uncommon condition characterized by the presence of mucinous gelatinous material in the peritoneal ..
  84. ncbi CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases
    D Nonaka
    Department of Pathology, New York University Medical Center, New York, NY 10016, USA
    Histopathology 49:381-7. 2006
    ..CDX-2 status in pseudomyxoma peritonei (PMP) has been barely reported...
  85. ncbi Pseudomyxoma peritonei and mucinous pyometral fluid arising from an ovarian borderline mucinous tumor: case report
    K Niwa
    Department of Obstetrics and Gynecology, Gifu University School of Medicine, Gifu, Japan
    Eur J Gynaecol Oncol 28:145-6. 2007
    An extremely rare case of a pseudomyxoma peritonei (PMP) and mucinous pyometral fluid, possibly arising from an ovarian borderline mucinous tumor is reported...
  86. ncbi Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei
    I M Shih
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Surg Pathol 25:1095-9. 2001
    b>Pseudomyxoma peritonei (PMP) is a clinical syndrome characterized by mucinous ascites and peritoneal lesions composed of histologically bland to low-grade adenomatous mucinous epithelium within pools of extracellular mucin, often with an ..
  87. ncbi Clinical presentation of pseudomyxoma peritonei
    P Jarvinen
    Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland
    Scand J Surg 99:213-6. 2010
    We analysed the clinical symptoms and signs of pseudomyxoma peritonei (PMP), a rare syndrome affecting one to two persons per million annually. Presumably, patients with PMP would benefit from early diagnosis...
  88. ncbi Pseudomyxoma peritonei: a case of mucinous adenocarcinoma of the appendix presenting as inguinal hernia
    M A Rezkalla
    Loma Linda VA Medical Center, USA
    S D Med 59:54-5, 57. 2006
    b>Pseudomyxoma peritonei is a rare neoplastic condition characterized by diffuse collections of gelatinous fluid associated with mucinous implants on the peritoneal surfaces and omentum...
  89. ncbi Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm
    Elizabeth M Murphy
    Pseudomyxoma Peritonei Centre, Colorectal Research Unit, North Hampshire Hospital, Basingstoke, Hampshire, United Kingdom
    Dis Colon Rectum 50:37-42. 2007
    ..Occult rupture with features of pseudomyxoma peritonei may be encountered...
  90. ncbi Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei
    Brigitte M Ronnett
    Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland 1231, USA
    Am J Surg Pathol 27:650-7. 2003
    Recent studies have redefined pseudomyxoma peritonei (PMP) as a specific clinicopathologic syndrome in which mucinous ascites is accompanied by peritoneal lesions characterized by bland to low-grade adenomatous mucinous epithelium ..
  91. ncbi Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei
    Jesse K McKenney
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
    Am J Surg Pathol 32:645-55. 2008
    ..recent study, their full histologic spectrum, detailed immunophenotype, and association with classic pseudomyxoma peritonei (PMP) have not been fully studied...
  92. ncbi A rare case of pseudomyxoma peritonei presenting an unusual inguinal hernia and splenic metastasis
    S Shimoyama
    Department of Gastrointestinal Surgery, University of Tokyo, Tokyo, Japan
    J Gastroenterol Hepatol 16:825-9. 2001
    b>Pseudomyxoma peritonei (PMP) is a rare clinical entity in which a diffuse collection of intraperitoneal gelatinous fluid is associated with gelatinous implants on the peritoneal surfaces and omentum...
  93. pmc Pseudomyxoma peritonei: unusual origin from an ovarian mature cystic teratoma
    N Pranesh
    Department of Surgery, Christie Hospital NHS Trust, Withington, Manchester M20 4BX, UK
    J Clin Pathol 58:1115-7. 2005
    b>Pseudomyxoma peritonei (PMP) is classified into pathologically and prognostically distinct categories, such as disseminated peritoneal adenomucinosis (DPAM) and peritoneal mucinous carcinomatosis...
  94. ncbi Appendiceal neoplasms and pseudomyxoma peritonei: a population based study
    R M Smeenk
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Eur J Surg Oncol 34:196-201. 2008
    b>Pseudomyxoma peritonei (PMP) is a rare disease with an estimated incidence of 1 per million per year, and is thought to originate usually from an appendiceal mucinous epithelial neoplasm...
  95. ncbi [Mucocele of the appendix and pseudomyxoma peritonei]
    A Fairise
    Service de Radiologie Adultes, CHU Nancy Brabois, Allee du Morvan, Vandoeuvre les Nancy Cedex, France
    J Radiol 89:751-62. 2008
  96. pmc Urachal adenocarcinoma in situ with pseudomyxoma peritonei: a case report
    G Stenhouse
    Department of Pathology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZD, UK
    J Clin Pathol 56:152-3. 2003
    ..At laparotomy, pseudomyxoma peritonei was discovered, together with a midline abdominal mass adherent to the anterior abdominal wall originating ..
  97. ncbi Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Dario Baratti
    Department of Surgery, National Cancer Institute, Milan, Italy
    Ann Surg Oncol 15:526-34. 2008
    ..hyperthermic intraperitoneal chemotherapy (HIPEC) has been recently advocated as the standard of care for pseudomyxoma peritonei (PMP)...
  98. ncbi Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy
    S van Ruth
    Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Ann Surg Oncol 9:961-7. 2002
    ..9 (CA19.9) measurements in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
  99. pmc Closed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugs
    Laurent Benoit
    Service de Chirurgie Digestive, Thoracique et Cancérologique, CHU du Bocage, 2 Bd Mal de Lattre de Tassigny, 21079 Dijon Cedex, France
    Ann Surg Oncol 15:542-6. 2008
    ..With open-abdomen HIPEC, the opposite is true. Although the open-abdomen method is potentially more effective, it has not become a standard procedure because of the risk of exposure of members of the team to drugs...
  100. ncbi Management of mucinous urachal neoplasm presenting as pseudomyxoma peritonei
    Paul H Sugarbaker
    Washington Cancer Institute, Washington, DC 20010, USA
    Tumori 94:732-6. 2008
    ..Mucinous neoplasms of the urachus are rare malignancies so that the physicians' index of suspicion for a timely and accurate diagnosis is low. Also, this disease may present with a wide variety of symptoms and signs...
  101. ncbi Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei
    Sonia A Butterworth
    Department of Surgery, British Columbia Cancer Agency, University of British Columbia, 855 West 10th Ave, Vancouver, BC, Canada V5Z 1L7
    Am J Surg 183:529-32. 2002
    Many centers include intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei. This study documented the morbidity of intraperitoneal chemotherapy in a single institution.

Research Grants1

  1. TK-based methods to improve radioimmunotherapy
    Janina Baranowska Kortylewicz; Fiscal Year: 2006
    ..Parameters such as the radioisotope uptake, tumor responses to augmented RIT, changes in tumor physiology, to improved clinical radioimmunotherapy of pancreatic cancer. ..